IndraLab

Statements

Macrocycle inhibits USP9X. 1 / 1

| 1

reach

"Ensemble Therapeutics has presented data describing the use of DECLs to develop macrocycle compounds (Mullard, 2016) that selectively and potently inhibit USP9x (Dodge, 2016), a DUB that is associated with many cancers (Murtaza, Jolly, Gecz, & Wood, 2015)."

30851297

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Macrocycle inhibits USP9X. 1 / 1

INDRA sources:

Databases

Reading